The history of NAFLD (MASLD) research
in Yokohama International Hepato-Biliary-Pancreatic-Gastroenterological Association

2024

Committee member for the Japanese naming of MASLD

APASL (Asia Pacific Association for the Study of the Liver ) guidelines committee member

Elucidating the prognosis of type 2 diabetes complicated by NAFLD globally. Lancet Gastroentrol Hepatol 2024

Therapeutic effect of tirzepatide (Phase 2 clinical trial).
NEJM 2024

2022/2023

Participating LITMUS Investigators, Europe’s Largest SLD Research Group

Global Clarification of Non-invasive Diagnostic Methods and Prognosis． Lancet Gastroentrol Hepatol 2022

Global Insights into the Prognosis of NAFLD with Type 2 Diabetes Comorbidity. Lancet Gastroentrol Hepatol 2023

2020

Member of Clinical Guidelines Development Committee (Gastroenterological Society / Hepatological Society)

Development of a new therapeutic drug using Lubiprostone
Lancet Gastroentrol Hepatol 2020

2019

Established GO Asia: Gut and Obesity in Asia Collaborative Research Group

2016

Establishing the Usefulness of MR Elastography for NAFLD Diagnosis．Gastroenterology 2016

First Report in the U.S.: Usefulness of Ultrasound Elastography (2D-SWE) for NAFLD Diagnosis ．
CGH 2016

2014

Guideline Committee Member, Japanese Society of Gastroenterology

2012

Elucidating the Mechanism of Obesity and Fatty Liver Inflammation Onset．Cell Metabolism 2012

2010

Establishment of the JSG-NAFLD collaborate research group

First report on the utility of ultrasound elastography (ARFI) for diagnosing NAFLD.
Radiology 2010

First Report in JPN: PNPLA3 Gene Involvement in the Onset of NAFLD. BMC Medical Genetics 2012

2007

World‘s First Report: Report on the Utility of Ultrasound Elastography (FibroScan®) for NAFLD Diagnosis. Gut 2007

2003

Opened Japan’s First Fatty Liver Clinic

• Over 250 published English papers
• Committee member for the development of international guidelines in Japan and Other Asian countries
• Japan’s representative in the International Naming of MASLD
• Committee member for the Japanese naming of MASLD
• Currently Conducting Numerous Global Clinical Trials for New Drug Development
• Supervising textbooks such as “Yearnote”